Article
STAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes.
International journal of clinical and experimental pathology - 1 Jan 2015
Zhao Ling, Zhang Qingyuan, Luan Xin, Huang Xu, Zhao Shu, Zhao Hong
Abstract excerpt
We conducted a case-control study in a Chinese population, and investigated the role of STAT3 rs4796793 and STAT5b rs6503691 polymorphisms in the risk and clinical outcome of breast cancer. STAT5b rs6503691 polymorphisms and STAT3 rs4796793 polymorphisms were genotyped by TaqMan SNP Genotyping Assays on the ABI 7500 fast real-time PCR platform. Unconditional logistic regression analyses showed that subjects...
Read the complete abstract on PubMed